Shopping Cart
Search
Close this search box.

Clinical Trial Record

Diagnosing and Treating Low Blood Sugar Levels


1991-05-21


N/A


N/A


1500

Study Overview

Diagnosing and Treating Low Blood Sugar Levels

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed....

Study Description: The purpose of this study is to gain knowledge and experience in the diagnosis and therapy of patients with fasting hypoglycemia due to diverse etiologies, such as insulinomas. Study subjects will be evaluated and treated for their particular condition according to standard care. Objectives: 1. To understand the pathophysiology and various causes of hypoglycemia (e.g., insulinomas, MEN1, MEN2). 2. To identify new circulating biomarkers of insulinomas. 3. To create a repository of clinical data and samples for future research of insulinomas. Endpoints: None

  • Hypoglycemia
  • Insulinoma
    • 910066
    • 91-DK-0066

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    1999-11-03  

    N/A  

    2024-04-10  

    1999-11-03  

    N/A  

    2024-05-15  

    1999-11-04  

    N/A  

    2024-02-01  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:


    Allocation:


    Interventional Model:


    Masking:


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : Patients with hypoglycemia

    Patients with hypoglycemia due to diverse etiologies.

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    Treatment Outcomesresolution of hypoglycemiaevery 1-3 months
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Craig S Cochran, R.N.

    Phone Number: (301) 402-1880

    Email: [email protected]

    Study Contact Backup

    Name: Ranganath Muniyappa, M.D.

    Phone Number: (301) 451-7702

    Email: [email protected]

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:


    • INCLUSION CRITERIA:

    • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
      1. Male, females ages >= 18. 2. Patients with documented fasting blood glucose below 55 mg/dl.
      4. Patients with biochemical evidence for insulinoma or other pancreatic neuroendocrine tumors.
      EXCLUSION CRITERIA:
      An individual who meets any of the following criteria will be excluded from participation in this study:
      1. Patients with significant cardiac disease will be excluded. 2. Subjects who are pregnant per self-report. 3. Medically unstable per the assessment of the PI.

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.

    • No Records Found

    • Principal investigator: Ranganath Muniyappa, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available